Trader consensus implies an 89.5% probability of no new pandemic in 2026, driven by the absence of any novel pathogen demonstrating sustained human-to-human transmission capable of overwhelming global health systems, per WHO criteria. Global surveillance from CDC, WHO, and PAHO reports no escalations: the recent hantavirus (Andes strain) cluster on cruise ship MV Hondius yielded only about eight cases and three deaths, with officials emphasizing very low public risk due to rodent-exposure transmission rather than respiratory spread. H5N1 avian influenza shows sporadic human infections—75 confirmed in the Americas since 2022—but lacks adaptation for efficient spread, while mpox clade I/II remains regionally contained. Post-COVID preparedness bolsters confidence, though experts monitor bird flu and vaccine-preventable diseases like measles; next WHO epidemiological updates expected soon.